Inhalation Vaccines Changing Options to Prevent and Control Transmission of Flu and COVID with Dr. Shankar Musunuri Ocugen TRANSCRIPT
Download PDFMay 13, 2023
Dr. Shankar Musunuri is the Co-Founder and CEO of Ocugen, which is a biotechnology company focused on vaccines for public health, gene therapies targeting rare diseases in the retinal space, and cell therapies for regenerative medicine applications in cartilage repair. One key opportunity is to develop an...
May 13, 2023
Dr. Shankar Musunuri is the Co-Founder and CEO of Ocugen, which is a biotechnology company focused on vaccines for public health, gene therapies targeting rare diseases in the retinal space, and cell therapies for regenerative medicine applications in cartilage repair. One key opportunity is to develop an...
Oral Gut Microbiome Treatment for Recurrent C. diff with Eric Shaff Seres Therapeutics TRANSCRIPT
Download PDFMay 1, 2023
Eric Shaff is the President and CEO of Seres Therapeutics, which is focused on the gut microbiome in order to develop bacteria as an oral treatment for bloodstream infections, cancer, and immune system diseases. The first therapy is SER-109 for recurrent C. diff infection an orphan disease with inadequate solutions...
May 1, 2023
Eric Shaff is the President and CEO of Seres Therapeutics, which is focused on the gut microbiome in order to develop bacteria as an oral treatment for bloodstream infections, cancer, and immune system diseases. The first therapy is SER-109 for recurrent C. diff infection an orphan disease with inadequate solutions...
Cross-Spectrum Anti-Viral Compounds Needed for Seasonal and Pandemic Infections with Sam Lee Cocrystal Pharma TRANSCRIPT
Download PDFMar 15, 2023
Sam Lee is the Co-CEO and President of Cocrystal Pharma, focused on pandemic viruses and seasonal influenza to develop a drug that is cross-spectrum with a high barrier to drug resistance. Using computational data, as well as high-resolution X-ray data, their platform allows options for newly emerging viruses that also...